Analysis for MRSH

$186.54 +8.14 (+4.56%)

📈 Growth — 0/30
💰 Profitability — 16/20
🏦 Financial Health — 12/20
💵 Valuation — 10/20
⚠️ Risk — 5/10

Overall Score: 43/100

Summary:

📈 Growth & Financial Trajectory

Based on the Q1 2026 result, an 8-quarter trend cannot be derived from a single period. The quarter shows revenues of $7.60B and net income attributable to parent of $1.15B. Operating income of $1.75B yields an implied operating margin of about 23%. Diluted EPS is $2.37. Cash flow: net cash flow from operating activities -$0.69B, investing -$0.10B, financing +$0.11B; total net cash flow -$0.81B. Given data limitations, growth assessment is neutral.

💰 Margins & Cash Flow

Operating margin: approx 23% (1.75B / 7.60B).
Costs and expenses: $6.02B vs revenue; suggests healthy operating leverage, though gross margin isn’t disclosed.
Cash flow: -$0.69B from operations; -$0.10B from investing; +$0.11B from financing; overall cash burn of -$0.81B.

🛡️ Balance Sheet & Liquidity

Current assets $23.24B vs current liabilities $20.91B → current ratio ~ 1.11.
Total assets $58.55B; total liabilities $43.75B; equity $14.51B.
Long‑term debt $19.55B; leverage modest; liquidity appears resilient but needs ongoing cash generation.

⚠️ Key Drivers & Risks

Drivers: Risk management & financial services demand; diversified revenue mix.
Risks: Cash flow volatility in the near term; sensitivity to interest rates and regulatory/macroeconomic headwinds.